Fairly recent talk on e.g., Kontro / BEX + AUDIO only (NO video)
Timestamps as follows:
- 00:00:57 – Whole genome insights (Alex Bataller)
- 00:02:31 – Luspatercept and disease modification (Pinkal Desai)
- 00:05:42 – EPO-PRETAR trial and ESA-IPSS-M score benefits (Sophie Park)
- 00:10:39 – HMA plus venetoclax (context of the VERONA study)
- 00:12:07 – BEXMAB trial (Mika Kontro)
- 00:14:33 – TP53-mutated MDS challenges (Thomas Cluzeau)
- 00:16:08 – CLK inhibitor promise (Eytan Stein)